M.G. Shrimply's (fka ABVV)

[ernie44]

word is they went private

cashed in their chips and left investor suckers holding the bag

Abviva, Inc., formerly Genesis Bioventures, Inc. is a biomedical company focused on the development and commercialization of breast cancer diagnostic and therapeutic products. The Company is commercializing a breast cancer diagnostic technology licensed from the University of Michigan. The Mammastatin Serum Assay (MSA) is a breast cancer diagnostic risk assessment test developed by Abviva’s wholly owned subsidiary, Biomedical Diagnostics, LLC, (BDx). The MSA also demonstrated that women with breast cancer had no detectable levels of Mammastatin or very low levels. The MSA will initially be offered as a CLIA certified clinical laboratory service test to physicians and clinics through BDx. Abviva has the exclusive option to develop cancer therapeutic products from the Mammastatin technology. total scam boolchit